Rocket Pharmaceuticals (RCKT) Gets FDA Alignment on Heart Drug Trial. Can it Ease Safety Concerns?
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals Inc. (RCKT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 4,029,262 | $13,780,075 | +33% | 0.01% |
| 2. | Millennium Management Israel Englander | 4,000,344 | $13,681,176 | +29% | 0% |
| 3. | Newtyn Management Noah Levy And Eugene Dozortsev | 4,000,000 | $13,680,000 | +27% | 1.71% |
| 4. | Maverick Capital Lee Ainslie | 3,923,963 | $13,419,953 | +10% | 0.12% |
| 5. | AQR Capital Management Cliff Asness | 3,386,162 | $11,580,675 | +11% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.44 | 10,000 | $34,400.00 | 50,000 | 2026-01-02 | Filing | |
| $3.41 | 10,000 | $34,100.00 | 40,000 | 2025-08-27 | Filing | |
| $5.08 | 20,000 | $101,600.00 | 792,680 | 2025-04-10 | Filing | |
| $4.70 | 21,099 | $99,165.30 | 26,774 | 2025-04-09 | Filing | |
| $14.75 | 1,355,932 | $19,999,997.00 | 17,628,567 | 2022-10-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.40 | 75,364 | $256,463.69 | 598,489 | 2026-09-11 | Filing | |
| $3.38 | 631 | $2,133.41 | 673,853 | 2026-08-18 | Filing | |
| $3.38 | 2,293 | $7,752.63 | 1,056,594 | 2026-08-18 | Filing | |
| $3.38 | 2,837 | $9,591.90 | 1,058,887 | 2026-08-13 | Filing | |
| $3.38 | 3,493 | $11,809.83 | 674,484 | 2026-08-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 17,687,772 | $60,492,180 | 0.52% | |
| 2. | 9,923,962 | $33,939,951 | 0% | |
| 3. | 5,810,033 | $19,870,313 | 0% | |
| 4. | 4,865,551 | $16,640,184 | 0.01% | |
| 5. | 3,784,387 | $12,942,604 | 0% |
News See All
Is Rocket Pharmaceuticals, Inc. (RCKT) Poised for Recovery After Key Gene Therapy Program Milestone?
We recently compiled a list of the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds. Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) is one of the most promising stocks on our list.
10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds
In this article, we will be taking a look at the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds.
10 Best NASDAQ Stocks Under $5 to Buy Right Now
In this article, we will discuss the 10 Best NASDAQ Stocks Under $5 to Buy Right Now.
10 Penny Stocks with Potential to Rise 1000 Percent
In this article, we will explore 10 penny stocks with potential to rise 1000 percent.
Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best single digit stocks to buy according to analysts.
12 Best Single Digit Stocks to Buy According to Analysts
On January 27, Matt Stucky of Northwestern Mutual appeared on CNBC's 'Closing Bell Overtime' to discuss the shifting landscape of the 2026 stock market with a focus on the broadening of investor interest...
Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the stocks that will double in 2026.
20 Stocks That Will Double in 2026
On December 8, Kevin Mahn of Hennion & Walsh appeared on CNBC's 'Closing Bell Overtime' to discuss the potential for another bullish year, but with more volatility.
Is Rocket Pharmaceuticals (RCKT) One of the Best NASDAQ Stocks Under $5 to Buy Now?
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best NASDAQ stocks under $5 to buy now.
Hedge Fund Resource Center